SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: BIS Research | PRODUCT CODE: 2164985

Cover Image

PUBLISHER: BIS Research | PRODUCT CODE: 2164985

Nucleic Acid Isolation and Purification Market - A Global and Regional Analysis: Focus on Workflow, Source Type, Technology, Downstream Application, End User, and Country - Analysis and Forecast, 2026-2036

PUBLISHED:
PAGES: 376 Pages
DELIVERY TIME: 1-5 business days
SELECT AN OPTION
PDF and Excel (1-3 User License)
USD 3200
PDF and Excel (Global License)
USD 7500

Add to Cart

This report can be delivered within 1 working day.

Introduction to the Global Nucleic Acid Isolation and Purification Market

The global nucleic acid isolation and purification market, valued at $2,781.9 million in 2025, is projected to reach $4,863.3 million by 2036, with a compound annual growth rate (CAGR) of 5.08% from 2026 to 2036.

KEY MARKET STATISTICS
Forecast Period2026 - 2036
2026 Evaluation$2,962.7 Million
2036 Forecast$4,863.3 Million
CAGR5.08%

The global nucleic acid isolation and purification market supports the recovery of DNA and RNA from biological samples for molecular diagnostics, genomic research, precision medicine, and biopharmaceutical development. The study covers consumables (kits and reagents) and instruments used for isolation, extraction, purification, clean-up, concentration, and quality control/quantification. Applications include PCR, qPCR, next generation sequencing (NGS), cloning, microarray analysis, blotting, and other molecular workflows. Extraction requirements vary across genomic DNA, plasmid DNA, microbial and viral nucleic acids, and emerging cell-free DNA (cfDNA) and RNA (cfRNA) analyses. Demand is supported by growing genetic-testing menus, longitudinal cancer monitoring, infectious-disease testing, and the need to deliver sufficient yield, purity, and integrity from specimens such as blood, plasma, FFPE tissue, cells, saliva, and microbial samples. Repeated testing generates recurring demand for kits and reagents, while automation investments support instrument adoption.

Technology development is focused on magnetic particle purification, silica-based workflows, integrated automated extraction, and programmable liquid handling. Magnetic bead-based systems allow scalable binding, washing, and elution without repeated centrifugation, enabling reliable sample processing from diverse specimen matrices. Laboratories are increasingly adopting application-specific reagents and automation-compatible formats to minimize hands-on time and cross-contamination risks while improving reproducibility. Consumables form the larger market segment, while extraction platforms and quality-control instruments serve laboratories of different throughputs. Growth is moderated by equipment and recurring reagent costs, clinical IVD quality requirements, and the need to validate protocols across sample types and downstream assays. Key opportunities include large biobanks, population genomics, molecular testing in emerging markets, and standardized extraction products supporting cfDNA/cfRNA research and clinical applications.

Market Introduction

The global nucleic acid isolation and purification market has evolved from predominantly manual sample preparation toward integrated, high-throughput DNA and RNA workflows. Manufacturers combine extraction chemistries, spin columns, magnetic particles, liquid handling, and measurement technologies to help laboratories obtain nucleic acids suitable for sensitive downstream molecular testing. The product landscape includes recurring kits and reagents as well as automated and semi-automated extraction systems, robotic liquid handlers, spectrophotometers, and fluorometers. Commercial products address genomic and plasmid DNA, viral and microbial nucleic acids, genomic RNA, and circulating nucleic acids across research-use and clinical-diagnostic settings. Laboratories select solutions by specimen matrix, sample volume, yield, purity, throughput, workflow integration, and total cost per preparation.

Notable developments include automation-compatible magnetic bead chemistries, higher-molecular-weight DNA recovery for long-read sequencing, flexible cfRNA and cfDNA isolation, and extraction systems designed for variable sample loads. The market also benefits from expanding NGS use in clinical laboratories, repeated molecular monitoring, and wider public-health pathogen sequencing. Academic and research laboratories remain major users, alongside pharmaceutical and biotechnology companies, clinical diagnostic centers, CROs, and applied-testing settings. North America leads both consumables and instruments on account of its established molecular diagnostics infrastructure, research activity, and automated laboratory installed base. Asia-Pacific and other regions provide additional opportunities as genomic capacity expands, while purchasing and regulatory requirements vary by geography.

Industrial Impact

The global nucleic acid isolation and purification market plays an enabling role in molecular diagnostics, genomics, pharmaceutical research, and precision medicine by influencing the consistency of DNA and RNA inputs used in downstream assays. Leading suppliers, including Thermo Fisher Scientific Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Revvity, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, and Promega Corporation, compete through extraction chemistries, automated purification instruments, established distribution channels, and integrated workflows. Specialists such as Macherey-Nagel, New England Biolabs, Norgen Biotek, Omega Bio-tek, Zymo Research, AutoGen, Analytik Jena, and Tecan expand the range of sample-specific kits, liquid-handling platforms, and purification technologies. Increasing use of cfDNA, cfRNA, clinical NGS, and microbial sequencing places greater emphasis on contamination management, specimen compatibility, and reproducible recovery. The combined adoption of instruments and matched consumables also makes automation compatibility, reagent supply, customer support, validation requirements, and cost per sample central to purchasing decisions. These developments support laboratory efficiency but do not remove the need for verified extraction performance and fit with intended downstream assays.

Market Segmentation

Segmentation 1: By Product

  • Consumables (Kits and Reagents)
  • Instruments

Consumables to Lead the Global Nucleic Acid Isolation and Purification Market (by Product)

Based on product, consumables are expected to remain the leading segment, accounting for $1,726.2 million in 2024. The consumables segment is expected to maintain its leading position in the global nucleic acid isolation and purification market throughout the forecast period, primarily driven by the recurring demand for extraction and purification kits, reagents, magnetic beads, columns, and other essential consumables used in molecular testing and research workflows.

Segmentation 2: Consumables (by Workflow)

  • Sample Isolation/Extraction/Purification
  • DNA/RNA Clean-Up and Concentration
  • DNA/RNA Quantification

Sample Isolation/Extraction/Purification Segment to Lead the Global Nucleic Acid Isolation and Purification Consumables Market (by Workflow)

The sample isolation/extraction/purification segment is expected to dominate the global nucleic acid isolation and purification consumables market throughout the forecast period, primarily driven by the recurring demand for extraction kits, reagents, magnetic beads, and purification columns across molecular diagnostics and life sciences research. Nucleic acid extraction represents a critical initial step in molecular workflows, directly influencing the quality and reliability of downstream applications such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and genomic analysis. Increasing molecular testing volumes, expanding genomic research activities, and the growing adoption of automated nucleic acid sample preparation consumables and nucleic acid sample preparation instruments workflows are expected to further strengthen demand for extraction and purification consumables.

Segmentation 3: Consumables (by Source Type)

  • DNA
  • RNA

DNA to Lead the Global Nucleic Acid Isolation and Purification Consumables Market (by Source Type)

The DNA segment is expected to account for the largest share of the global nucleic acid isolation and purification consumables market, supported by its extensive utilization across genomics research, molecular diagnostics, genetic testing, and biotechnology applications. DNA extraction and purification are essential for numerous downstream applications, including NGS, PCR-based analysis, genotyping, mutation detection, and molecular cloning. The increasing adoption of genomic testing in oncology, hereditary disease screening, and precision medicine is expected to generate sustained demand for DNA isolation and purification consumables.

Segmentation 4: Consumables (by Technology)

  • Silica-Based Technology
  • Magnetic Particle Technology
  • Other Technologies

Magnetic Particle Technology to Lead the Global Nucleic Acid Isolation and Purification Consumables Market (by Technology)

The magnetic particle technology segment is expected to maintain its leading position in the global nucleic acid isolation and purification consumables market, driven by its compatibility with automated workflows, scalability, and ability to deliver consistent nucleic acid recovery across diverse sample types. Magnetic bead-based extraction enables efficient separation and purification of DNA and RNA while reducing manual handling and dependence on centrifugation-based processes.

Segmentation 5: Consumables (by Downstream Application)

  • PCR
  • qPCR
  • NGS
  • Cloning
  • Microarray
  • Blotting Techniques
  • Other Applications

qPCR to Lead the Global Nucleic Acid Isolation and Purification Consumables Market (by Downstream Application)

The quantitative polymerase chain reaction (qPCR) segment is expected to hold the largest share of the global nucleic acid isolation and purification consumables market by downstream application, primarily supported by its widespread utilization in molecular diagnostics, infectious disease testing, gene expression analysis, and genetic research. The technique's established clinical utility, relatively rapid turnaround time, and compatibility with standardized laboratory workflows contribute to its extensive adoption across diagnostic and research settings. As reliable qPCR analysis requires nucleic acid samples of adequate purity and quality, routine testing activities generate recurring demand for extraction and purification consumables.

Segmentation 6: Consumables (by End User)

  • Academic Research Institutes and Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Applied Testing
  • Clinical Diagnostic Centers

Academic Research Institutes and Laboratories to Lead the Global Nucleic Acid Isolation and Purification Consumables Market (by End User)

Academic research institutes and laboratories are expected to account for the largest share of the global nucleic acid isolation and purification consumables market, supported by extensive nucleic acid-based research activities across molecular biology, genomics, genetics, microbiology, and biotechnology. These institutions routinely utilize extraction and purification kits, reagents, and other consumables for experimental studies, sequencing workflows, gene expression analysis, and molecular characterization. The diversity of research projects and continuous processing of biological samples create recurring demand for consumables across multiple workflows.

Segmentation 7: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Poland
    • Portugal
    • Russia
    • Rest-of-Europe
  • Asia-Pacific
    • Australia
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Thailand
    • Taiwan
    • Singapore
    • Indonesia
    • Philippines
    • Rest-of-Asia-Pacific
  • Latin America
    • Argentina
    • Brazil
    • Chile
    • Mexico
    • Colombia
    • Rest-of-Latin America
  • Middle East and Africa
    • U.A.E.
    • K.S.A.
    • South Africa
    • Rest-of-Middle East and Africa

North America to Lead the Global Nucleic Acid Isolation and Purification Consumables Market (by Region)

North America is expected to maintain its leading position in the global nucleic acid isolation and purification consumables market, driven by its established molecular diagnostics infrastructure, extensive genomics research activities, and strong presence of biotechnology and pharmaceutical companies. The region benefits from a well-developed network of academic research institutions, clinical laboratories, and genomic testing facilities that generate consistent demand for nucleic acid extraction and purification products. Increasing utilization of molecular diagnostics, expansion of precision medicine applications, and continued adoption of advanced sequencing technologies are expected to support consumables demand.

Segmentation 8: Instruments (by Workflow)

  • Isolation/Extraction/Purification
  • Quality Control/Quantification

Isolation/Extraction/Purification Segment to Lead the Global Nucleic Acid Isolation and Purification Instruments Market (by Workflow)

The isolation/extraction/purification segment is expected to dominate the global nucleic acid isolation and purification instruments market throughout the forecast period, primarily driven by the increasing adoption of automated sample preparation systems across molecular diagnostics, genomics research, and biotechnology applications. These instruments facilitate efficient extraction and purification of DNA and RNA from diverse biological samples while reducing manual intervention, processing variability, and the risk of contamination. The growing need for standardized sample preparation, improved laboratory productivity, and consistent nucleic acid quality is encouraging laboratories to transition from manual extraction methods toward automated platforms.

Segmentation 9: Instruments (by Technology)

  • Automated Spin-Column Based
  • Magnetic Bead-Based
  • Automated Liquid Handling

Magnetic Bead-Based Segment to Lead the Global Nucleic Acid Isolation and Purification Instruments Market (by Technology)

The magnetic bead-based segment is expected to account for the largest share of the global nucleic acid isolation and purification instruments market, supported by the growing adoption of automated magnetic particle processing systems across clinical and research laboratories. Magnetic bead-based instruments enable efficient nucleic acid extraction through automated binding, washing, and elution processes, offering advantages in workflow standardization, reproducibility, and operational efficiency.

Segmentation 10: Instruments (by Throughput)

  • Low-Throughput Instruments
  • Medium-Throughput Instruments
  • High-Throughput Instruments

Medium-Throughput Instruments Segment to Lead the Global Nucleic Acid Isolation and Purification Instruments Market (by Throughput)

The medium-throughput instruments segment is expected to maintain its leading position in the global nucleic acid isolation and purification instruments market, primarily driven by its ability to balance sample processing capacity, operational flexibility, and capital investment requirements. Medium-throughput extraction systems are particularly suitable for academic research laboratories, hospital laboratories, and molecular diagnostic facilities handling moderate or variable sample volumes. These instruments enable laboratories to automate routine nucleic acid extraction workflows without requiring the higher capital expenditure, laboratory space, and sample volumes generally associated with large-scale automated systems.

Segmentation 11: Instruments (by End User)

  • Academic Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Clinical Diagnostic Centers
  • Applied Testing (Biobanks, Forensic and Veterinary Laboratories)
  • Contract Research Organizations

Academic Research Institutes to Lead the Global Nucleic Acid Isolation and Purification Instruments Market (by End User)

Academic research institutes are expected to hold the largest share of the global nucleic acid isolation and purification instruments market, supported by the extensive use of nucleic acid extraction technologies in genomics, molecular biology, microbiology, and biomedical research. These institutions require reliable and versatile sample preparation instruments to support diverse experimental workflows, including gene expression studies, genetic characterization, sequencing, and molecular assay development. Increasing research complexity and the need for consistent sample quality are encouraging laboratories to adopt automated extraction systems that improve productivity and reduce manual processing requirements.

Segmentation 12: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Poland
    • Portugal
    • Russia
    • Rest-of-Europe
  • Asia-Pacific
    • Australia
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Thailand
    • Taiwan
    • Singapore
    • Indonesia
    • Philippines
    • Rest-of-Asia-Pacific
  • Latin America
    • Argentina
    • Brazil
    • Chile
    • Mexico
    • Colombia
    • Rest-of-Latin America
  • Middle East and Africa
    • U.A.E.
    • K.S.A.
    • South Africa
    • Rest-of-Middle East and Africa

North America to Lead the Global Nucleic Acid Isolation and Purification Instruments Market (by Region)

North America is expected to retain its leading position in the global nucleic acid isolation and purification instruments market, driven by its advanced laboratory infrastructure, established biotechnology industry, and extensive adoption of automated molecular testing technologies. The region has a substantial concentration of academic research institutes, pharmaceutical and biotechnology companies, molecular diagnostic laboratories, and genomic research centers that require efficient and standardized nucleic acid extraction systems.

Recent Developments in the Global Nucleic Acid Isolation and Purification Market

  • In August 2026, New England Biolabs, Inc. launched the Monarch Mag Cell-free RNA (cfRNA) Extraction Kit, a phenol-free magnetic bead-based kit for isolating low-abundance circulating cfRNA and exome-associated RNA from plasma, serum, urine, and cerebrospinal fluid for downstream sequencing and amplification workflows.
  • In July 2026, QIAGEN N.V. established a life-sciences distribution partnership with Hamburg Trading Corporation and opened a QIAGEN Experience Lab in the Philippines. The facility provides local demonstrations and technical workshops for laboratory-automation systems, including QIAsprint Connect and QIAcube Connect
  • In June 2026, Omega Bio-tek, Inc. launched the Mag-Bind High Molecular Weight DNA Kit (M6311), a magnetic bead-based kit supporting manual and automated purification of genomic DNA fragments up to 450 kb from whole blood, buffy coat, saliva, and cultured cells for long-read sequencing workflows.

Demand - Drivers, Challenges, and Opportunities

Market Drivers

Growing Burden of Cancer and Infectious Diseases Expanding Molecular Testing Volumes: Expansion of molecular testing is supporting recurring demand for nucleic acid isolation and purification kits, reagents, and integrated systems. DNA and RNA sample preparation is a necessary upstream step for many PCR- and NGS-based analyses used in cancer profiling, inherited-disease testing, pathogen detection, and disease monitoring. Increasing testing penetration and more frequent molecular assessments therefore contribute to greater extraction volumes rather than cancer or infection incidence, translating directly into product sales. Rising clinical NGS utilization, pathogen genomic surveillance, and diversification of genetic testing further increase the variety of specimens requiring standardized workflows. Manufacturers offering consistent yield, purity, automation, and sample-matrix compatibility are positioned to serve growing requirements across clinical diagnostics, genomics facilities, and research laboratories.

Market Challenges

High Capital and Recurring Costs of Nucleic Acid Isolation and Purification: Capital expenditure on automated extraction platforms, robotic liquid handling, and associated quality-control instruments remains a barrier for laboratories with limited budgets or variable sample volumes. Day-to-day use also generates recurring expenditure on compatible kits, reagents, plasticware, maintenance, calibration, and trained personnel. Technology selection must consider cost per preparation, expected utilization, specimen-specific recovery, and compatibility with downstream assays. Laboratories with highly diverse sample matrices may require additional consumable formats and validation efforts, reducing the savings of standardized automation. Clinical diagnostic products can incur further documentation, quality-management, and regulatory obligations tied to intended use and jurisdiction. These factors can slow automation uptake in smaller or resource-constrained facilities even when molecular testing demand is increasing.

Market Opportunities

Shift toward Standardized, Ready-to-Use, and Automation-Compatible Isolation and Purification Consumables: Demand for reproducible, efficient sample preparation is creating opportunities for suppliers of validated kits, prefilled reagents, magnetic beads, and instrument-compatible consumable formats. Centralized molecular laboratories increasingly seek standardized workflows that reduce operator variability, manual handling, and contamination risk while supporting flexible sample volumes and predictable per-test costs. The opportunity extends to high-quality cfDNA and cfRNA extraction, pathogen and microbial sequencing, liquid-biopsy workflows, and large-scale biobanking. These settings often need reliable nucleic acid recovery from challenging matrices as well as connectivity with automated extraction and downstream PCR, qPCR, or NGS systems. Manufacturers that combine ready-to-use reagents with scalable automation, supply reliability, and transparent performance data may be better positioned to expand adoption in both advanced and emerging laboratory markets.

How can this report add value to an organization?

Product/Innovation Strategy: The global nucleic acid isolation and purification market is segmented by product type and, separately for consumables and instruments, by workflow, technology, end user, and geography. The analysis also details consumable source types and downstream applications, together with instrument throughput. This framework helps manufacturers target magnetic bead and silica chemistries, automated isolation systems, cfDNA/cfRNA kits, and quality-control workflows based on application needs and segment growth.

Growth/Marketing Strategy: The study examines expanding clinical NGS use, population biobanking, molecular diagnostics, and automation-linked consumables alongside regional and country-level differences in purchasing capacity. It helps companies evaluate channel strategies, laboratory segmentation, instrument placement, recurring reagent demand, and growth opportunities in underserved genomic-testing markets. Partnerships, product launches, and distributor expansion also provide context for commercialization strategies.

Competitive Strategy: Competition spans broad-based life-sciences manufacturers and specialized nucleic acid extraction vendors. The report benchmarks consumables and instruments, including product coverage by DNA/RNA source type and preparation technology, and reviews strategic developments from leading participants. Organizations can use these findings to evaluate integrated instrument-and-reagent positioning, compare magnetic-bead and silica offerings, identify unmet workflow needs, and assess partnership or portfolio-expansion opportunities.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2024 to 2036 have been considered for the global market size estimation; 2025 has been considered as the base year, and 2026 to 2036 as the forecast period.
  • Market estimates cover commercial nucleic acid isolation and purification consumables and instruments used across molecular diagnostics, genomics research, pharmaceutical/biotechnology laboratories, CROs, academic research, and applied-testing settings.
  • The analysis separately assesses consumables and instruments and applies regional and country-level demand estimates across five major geographic regions.
  • Revenues from companies have been sourced from their annual reports for FY2024 and FY2025. For private companies, revenue estimates are derived from primary research inputs, funding history, market collaborations, and operational performance.
  • The study evaluates existing technologies and adoption trends. Forecasts use stated assumptions and proxies where data are unavailable and exclude service revenues outside the product market.

Primary Research

The primary research sources include industry experts and stakeholders working in nucleic acid extraction, purification, and laboratory automation. Respondents include company executives, marketing and technology leaders, laboratory users, healthcare experts, and clinical application specialists. Their inputs support validation of quantitative estimates, product segmentation, adoption trends, geographical splits, competitive positioning, and qualitative analysis of market opportunities and restraints.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of report segmentations and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investors' presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Agilent Technologies, Inc.
  • Analytik Jena GmbH+Co. KG
  • AutoGen Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • Macherey-Nagel GmbH & Co. KG
  • New England Biolabs
  • Norgen Biotek Corp
  • Omega Bio-tek, Inc.
  • Orasure Technologies, Inc.
  • Revvity, Inc. (PerkinElmer, Inc.)
  • Promega Corporation
  • QIAGEN N.V.
  • Sage Science, Inc.
  • Tecan Group
  • Thermo Fisher Scientific Inc.
  • Zymo Research
Product Code: BHP0827SC

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Overview and Ecosystem
  • 1.2 Nucleic Acid Isolation and Purification Automation Applications
    • 1.2.1 Genomic/Plasmid DNA Extraction
    • 1.2.2 Cell-Free DNA (cfDNA) Extraction
    • 1.2.3 Viral RNA Extraction
    • 1.2.4 Cell-Free RNA Extraction
  • 1.3 Market Trends
    • 1.3.1 Transition from Episodic Testing to Longitudinal Molecular Testing Driving Repeat Isolation and Purification Workflows
    • 1.3.2 Increasing Diversity of Sample Types Driving Matrix-Specific Isolation and Purification Workflows
    • 1.3.3 Expansion from cfDNA to cfRNA and Total Cell-Free Nucleic Acid Isolation and Purification
  • 1.4 Pricing Analysis
    • 1.4.1 Pricing Analysis (Consumables)
    • 1.4.2 Pricing Analysis (Instruments)
  • 1.5 Investment Analysis
  • 1.6 Supply Chain Analysis
  • 1.7 Regulatory Outlook
  • 1.8 Market Dynamics
    • 1.8.1 Market Drivers
      • 1.8.1.1 Growing Burden of Cancer and Infectious Diseases Expanding Molecular Testing Volumes
      • 1.8.1.2 Expansion and Diversification of Genetic Testing
      • 1.8.1.3 Expansion of Microbial and Pathogen Genomic Sequencing
      • 1.8.1.4 Increasing Adoption of NGS-Based Testing in Clinical Laboratories
    • 1.8.2 Market Restraints
      • 1.8.2.1 Genomic Data Protection
      • 1.8.2.2 High Capital and Recurring Costs of Nucleic Acid Isolation and Purification
      • 1.8.2.3 Stringent Regulatory and Quality Compliance Requirements
    • 1.8.3 Market Opportunities
      • 1.8.3.1 Expansion of Biobanks and Population-Scale Genomic Research
      • 1.8.3.2 Shift toward Standardized, Ready-to-Use, and Automation-Compatible Isolation and Purification Consumables
      • 1.8.3.3 Expansion of Flexible Acquisition Models for Cost-Constrained Laboratories
      • 1.8.3.4 Expansion in Underpenetrated Emerging Markets

2 Global Nucleic Acid Isolation and Purification Market, Product Type

  • 2.1 Product Type Summary
    • 2.1.1 Consumables
      • 2.1.1.1 Kits
      • 2.1.1.2 Reagents
    • 2.1.2 Instruments

3 Global Nucleic Acid Isolation and Purification Consumables Market, Workflow

  • 3.1 Workflow Summary
  • 3.2 Sample Isolation/Extraction/Purification
  • 3.3 DNA/RNA Clean-Up and Concentration
  • 3.4 DNA/RNA Quantification

4 Global Nucleic Acid Isolation and Purification Consumables Market, by Source Type

  • 4.1 Source Type Summary
  • 4.2 DNA
    • 4.2.1 Cell-Free DNA
      • 4.2.1.1 By Sample
        • 4.2.1.1.1 Blood
        • 4.2.1.1.2 Serum/Plasma
        • 4.2.1.1.3 Other Sources
      • 4.2.1.2 By Application
        • 4.2.1.2.1 Prenatal and Hereditary Testing
        • 4.2.1.2.2 Tumor Testing
        • 4.2.1.2.3 Transplantation
    • 4.2.2 Genomic DNA
      • 4.2.2.1 Blood
      • 4.2.2.2 Body Fluids
      • 4.2.2.3 Buccal
      • 4.2.2.4 Cell/Cultured Cell
      • 4.2.2.5 FFPE
      • 4.2.2.6 Forensic
      • 4.2.2.7 Plant
      • 4.2.2.8 Saliva/Swab
      • 4.2.2.9 Serum/Plasma
      • 4.2.2.10 Tissue
      • 4.2.2.11 Stool, Urine, and Other Samples
    • 4.2.3 Microbial DNA
      • 4.2.3.1 Bacterial
      • 4.2.3.2 Fungus
      • 4.2.3.3 Yeast
      • 4.2.3.4 Other Sources
    • 4.2.4 Plasmid DNA
      • 4.2.4.1 GigaPrep
      • 4.2.4.2 MaxiPrep
      • 4.2.4.3 MegaPrep
      • 4.2.4.4 MidiPrep
      • 4.2.4.5 MiniPrep
    • 4.2.5 Viral DNA
  • 4.3 RNA
      • 4.3.1.1 Genomic RNA
        • 4.3.1.1.1 Blood
        • 4.3.1.1.2 Body Fluids
        • 4.3.1.1.3 Cell/Cultured Cell
        • 4.3.1.1.4 FFPE
        • 4.3.1.1.5 Plant
        • 4.3.1.1.6 Saliva/Swab
        • 4.3.1.1.7 Serum/Plasma
        • 4.3.1.1.8 Tissue
        • 4.3.1.1.9 Urine
        • 4.3.1.1.10 Others
      • 4.3.1.2 Microbial RNA
        • 4.3.1.2.1 Bacteria
        • 4.3.1.2.2 Yeast
        • 4.3.1.2.3 Fungus
        • 4.3.1.2.4 Others
      • 4.3.1.3 Viral RNA
      • 4.3.1.4 Cell-Free RNA
        • 4.3.1.4.1 Serum/Plasma
        • 4.3.1.4.2 Others

5 Global Nucleic Acid Isolation and Purification Consumables Market, By Technology

  • 5.1 Technology Summary
  • 5.2 Silica-Based Technology
  • 5.3 Magnetic Particle Technology
  • 5.4 Other Technologies

6 Global Nucleic Acid Isolation and Purification Consumables Market, By Downstream Application

  • 6.1 Downstream Applications Summary
  • 6.2 PCR
  • 6.3 qPCR
  • 6.4 NGS
  • 6.5 Cloning
  • 6.6 Microarray
  • 6.7 Blotting Techniques
  • 6.8 Other Applications

7 Global Nucleic Acid Isolation and Purification Consumables Market, By End User

  • 7.1 End User Summary
  • 7.2 Academic Research Institutes and Laboratories
  • 7.3 Pharmaceutical and Biotechnology Companies
  • 7.4 Contract Research Organizations
  • 7.5 Applied Testing
  • 7.6 Clinical Diagnostic Centers

8 Global Nucleic Acid Isolation and Purification Consumables Market, 2024-2036, by Region

  • 8.1 Regional Summary
  • 8.2 North America
    • 8.2.1 Regional Overview
    • 8.2.2 Driving Factors for Market Growth
    • 8.2.3 Factors Challenging the Market
    • 8.2.4 By Country
      • 8.2.4.1 U.S.
      • 8.2.4.2 Canada
  • 8.3 Europe
    • 8.3.1 Regional Overview
    • 8.3.2 Driving Factors for Market Growth
    • 8.3.3 Factors Challenging the Market
    • 8.3.4 By Country
      • 8.3.4.1 Germany
      • 8.3.4.2 U.K.
      • 8.3.4.3 France
      • 8.3.4.4 Italy
      • 8.3.4.5 Spain
      • 8.3.4.6 Netherlands
      • 8.3.4.7 Poland
      • 8.3.4.8 Portugal
      • 8.3.4.9 Russia
      • 8.3.4.10 Rest-of-Europe
  • 8.4 Asia Pacific
    • 8.4.1 Regional Overview
    • 8.4.2 Driving Factors for Market Growth
    • 8.4.3 Factors Challenging the Market
    • 8.4.4 By Country
      • 8.4.4.1 Australia
      • 8.4.4.2 China
      • 8.4.4.3 India
      • 8.4.4.4 Japan
      • 8.4.4.5 Malaysia
      • 8.4.4.6 South Korea
      • 8.4.4.7 Thailand
      • 8.4.4.8 Taiwan
      • 8.4.4.9 Singapore
      • 8.4.4.10 Indonesia
      • 8.4.4.11 Philippines
      • 8.4.4.12 Rest-of-Asia-Pacific
  • 8.5 Latin America
    • 8.5.1 Regional Overview
    • 8.5.2 Driving Factors for Market Growth
    • 8.5.3 Factors Challenging the Market
    • 8.5.4 By Country
      • 8.5.4.1 Argentina
      • 8.5.4.2 Brazil
      • 8.5.4.3 Chile
      • 8.5.4.4 Mexico
      • 8.5.4.5 Colombia
      • 8.5.4.6 Rest-of-Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Regional Overview
    • 8.6.2 Driving Factors for Market Growth
    • 8.6.3 Factors Challenging the Market
    • 8.6.4 By Country
      • 8.6.4.1 K.S.A.
      • 8.6.4.2 South Africa
      • 8.6.4.3 U.A.E.
      • 8.6.4.4 Rest-of-Middle East and Africa

9 Global Nucleic Acid Isolation and Purification Instruments Market, 2024-2036, by Workflow

  • 9.1 Overview
  • 9.2 Isolation/Extraction/Purification
  • 9.3 Quality Control/Quantification
    • 9.3.1 Quality Control/Quantification Instruments Market, by Technology
    • 9.3.2 Spectrophotometers
    • 9.3.3 Fluorometers
    • 9.3.4 Others

10 Global Nucleic Acid Isolation and Purification Instruments Market, 2024-2036, by Technology

  • 10.1 Overview
  • 10.2 Automated Spin-Column based
  • 10.3 Magnetic Bead Based Throughput
  • 10.4 Automated Liquid Handling

11 Global Nucleic Acid Isolation and Purification Instruments Market, 2024-2036, by Throughput

  • 11.1 Overview
  • 11.2 Low-Throughput Instruments
  • 11.3 Medium-Throughput Instruments
  • 11.4 High-Throughput Instruments

12 Global Nucleic Acid Isolation and Purification Instruments Market, 2024-2036, by End User

  • 12.1 Overview
  • 12.2 Academic Research Institute
  • 12.3 Pharmaceutical and Biotechnology Companies
  • 12.4 Clinical Diagnostic Centers
  • 12.5 Applied Testing (Biobanks, Forensic and Veterinary Laboratories)
  • 12.6 Contract Research Organizations

13 Global Nucleic Acid Isolation and Purification Instruments Market, 2024-2036, by Region

  • 13.1 Regional Summary
  • 13.2 North America
    • 13.2.1 Regional Overview
    • 13.2.2 Driving Factors for Market Growth
    • 13.2.3 Factors Challenging the Market
    • 13.2.4 By Country
      • 13.2.4.1 U.S.
      • 13.2.4.2 Canada
  • 13.3 Europe
    • 13.3.1 Regional Overview
    • 13.3.2 Driving Factors for Market Growth
    • 13.3.3 Factors Challenging the Market
    • 13.3.4 By Country
      • 13.3.4.1 Germany
      • 13.3.4.2 U.K.
      • 13.3.4.3 France
      • 13.3.4.4 Italy
      • 13.3.4.5 Spain
      • 13.3.4.6 Netherlands
      • 13.3.4.7 Poland
      • 13.3.4.8 Portugal
      • 13.3.4.9 Russia
      • 13.3.4.10 Rest-of-Europe
  • 13.4 Asia Pacific
    • 13.4.1 Regional Overview
    • 13.4.2 Driving Factors for Market Growth
    • 13.4.3 Factors Challenging the Market
    • 13.4.4 By Country
      • 13.4.4.1 Australia
      • 13.4.4.2 China
      • 13.4.4.3 India
      • 13.4.4.4 Japan
      • 13.4.4.5 Malaysia
      • 13.4.4.6 South Korea
      • 13.4.4.7 Thailand
      • 13.4.4.8 Taiwan
      • 13.4.4.9 Singapore
      • 13.4.4.10 Indonesia
      • 13.4.4.11 Philippines
      • 13.4.4.12 Rest-of-Asia-Pacific
  • 13.5 Latin America
    • 13.5.1 Regional Overview
    • 13.5.2 Driving Factors for Market Growth
    • 13.5.3 Factors Challenging the Market
    • 13.5.4 By Country
      • 13.5.4.1 Argentina
      • 13.5.4.2 Brazil
      • 13.5.4.3 Chile
      • 13.5.4.4 Mexico
      • 13.5.4.5 Colombia
      • 13.5.4.6 Rest-of-Latin America
  • 13.6 Middle East and Africa
    • 13.6.1 Regional Overview
    • 13.6.2 Driving Factors for Market Growth
    • 13.6.3 Factors Challenging the Market
    • 13.6.4 By Country
      • 13.6.4.1 K.S.A.
      • 13.6.4.2 South Africa
      • 13.6.4.3 U.A.E.
      • 13.6.4.4 Rest of the Middle East and Africa

14 Competitive Benchmarking and Company Profiles

  • 14.1 Product Benchmarking (Consumables)
    • 14.1.1 Product Benchmarking (by Source Type)
      • 14.1.1.1 DNA
      • 14.1.1.2 RNA
  • 14.2 Product Benchmarking (Instruments)
  • 14.3 Key Strategies and Developments (by Company)
    • 14.3.1 Partnerships, Collaborations, and Business Expansions
    • 14.3.2 New Offerings
  • 14.4 Company Profiles
    • 14.4.1 Agilent Technologies, Inc.
      • 14.4.1.1 Overview
      • 14.4.1.2 Top Products/Product Portfolio
      • 14.4.1.3 Top Competitors
      • 14.4.1.4 Target Customers
      • 14.4.1.5 Key Personnel
      • 14.4.1.6 Analyst View
    • 14.4.2 Analytik Jena GmbH+Co. KG
      • 14.4.2.1 Overview
      • 14.4.2.2 Top Products/Product Portfolio
      • 14.4.2.3 Top Competitors
      • 14.4.2.4 Target Customers
      • 14.4.2.5 Key Personnel
      • 14.4.2.6 Analyst View
    • 14.4.3 AutoGen Inc.
      • 14.4.3.1 Overview
      • 14.4.3.2 Top Products/Product Portfolio
      • 14.4.3.3 Top Competitors
      • 14.4.3.4 Target Customers
      • 14.4.3.5 Key Personnel
      • 14.4.3.6 Analyst View
    • 14.4.4 Bio-Rad Laboratories, Inc.
      • 14.4.4.1 Overview
      • 14.4.4.2 Top Products/Product Portfolio
      • 14.4.4.3 Top Competitors
      • 14.4.4.4 Target Customers
      • 14.4.4.5 Key Personnel
      • 14.4.4.6 Analyst View
    • 14.4.5 F. Hoffmann-La Roche AG
      • 14.4.5.1 Overview
      • 14.4.5.2 Top Products/Product Portfolio
      • 14.4.5.3 Top Competitors
      • 14.4.5.4 Target Customers
      • 14.4.5.5 Key Personnel
      • 14.4.5.6 Analyst View
    • 14.4.6 Merck KGaA
      • 14.4.6.1 Overview
      • 14.4.6.2 Top Products/Product Portfolio
      • 14.4.6.3 Top Competitors
      • 14.4.6.4 Target Customers
      • 14.4.6.5 Key Personnel
      • 14.4.6.6 Analyst View
    • 14.4.7 Macherey-Nagel GmbH & Co KG
      • 14.4.7.1 Overview
      • 14.4.7.2 Top Products/Product Portfolio
      • 14.4.7.3 Top Competitors
      • 14.4.7.4 Target Customers
      • 14.4.7.5 Key Personnel
      • 14.4.7.6 Analyst View
    • 14.4.8 New England Biolabs
      • 14.4.8.1 Overview
      • 14.4.8.2 Top Products/Product Portfolio
      • 14.4.8.3 Top Competitors
      • 14.4.8.4 Target Customers
      • 14.4.8.5 Key Personnel
      • 14.4.8.6 Analyst View
    • 14.4.9 Norgen Biotek Corp
      • 14.4.9.1 Overview
      • 14.4.9.2 Top Products/Product Portfolio
      • 14.4.9.3 Top Competitors
      • 14.4.9.4 Target Customers
      • 14.4.9.5 Key Personnel
      • 14.4.9.6 Analyst View
    • 14.4.10 Omega Bio-tek, Inc.
      • 14.4.10.1 Overview
      • 14.4.10.2 Top Products/Product Portfolio
      • 14.4.10.3 Top Competitors
      • 14.4.10.4 Target Customers
      • 14.4.10.5 Key Personnel
      • 14.4.10.6 Analyst View
    • 14.4.11 Orasure Technologies, Inc.
      • 14.4.11.1 Overview
      • 14.4.11.2 Top Products/Product Portfolio
      • 14.4.11.3 Top Competitors
      • 14.4.11.4 Target Customers
      • 14.4.11.5 Key Personnel
      • 14.4.11.6 Analyst View
    • 14.4.12 Revvity, Inc. (PerkinElmer, Inc.)
      • 14.4.12.1 Overview
      • 14.4.12.2 Top Products/Product Portfolio
      • 14.4.12.3 Top Competitors
      • 14.4.12.4 Target Customers
      • 14.4.12.5 Key Personnel
      • 14.4.12.6 Analyst View
    • 14.4.13 Promega Corporation
      • 14.4.13.1 Overview
      • 14.4.13.2 Top Products/Product Portfolio
      • 14.4.13.3 Top Competitors
      • 14.4.13.4 Target Customers
      • 14.4.13.5 Key Personnel
      • 14.4.13.6 Analyst View
    • 14.4.14 QIAGEN N.V.
      • 14.4.14.1 Overview
      • 14.4.14.2 Top Products/Product Portfolio
      • 14.4.14.3 Top Competitors
      • 14.4.14.4 Target Customers
      • 14.4.14.5 Key Personnel
      • 14.4.14.6 Analyst View
    • 14.4.15 Sage Science, Inc.
      • 14.4.15.1 Overview
      • 14.4.15.2 Top Products/Product Portfolio
      • 14.4.15.3 Top Competitors
      • 14.4.15.4 Target Customers
      • 14.4.15.5 Key Personal
      • 14.4.15.6 Analyst View
    • 14.4.16 Tecan Group
      • 14.4.16.1 Overview
      • 14.4.16.2 Top Products/Product Portfolio
      • 14.4.16.3 Top Competitors
      • 14.4.16.4 Target Customers
      • 14.4.16.5 Key Personal
      • 14.4.16.6 Analyst View
    • 14.4.17 Thermo Fisher Scientific Inc.
      • 14.4.17.1 Overview
      • 14.4.17.2 Top Products/Product Portfolio
      • 14.4.17.3 Top Competitors
      • 14.4.17.4 Target Customers
      • 14.4.17.5 Key Personnel
      • 14.4.17.6 Analyst View
    • 14.4.18 Zymo Research
      • 14.4.18.1 Overview
      • 14.4.18.2 Top Products/Product Portfolio
      • 14.4.18.3 Top Competitors
      • 14.4.18.4 Target Customers
      • 14.4.18.5 Key Personnel
      • 14.4.18.6 Analyst View

15 Research Methodology

  • 15.1 Data Sources
    • 15.1.1 Primary Data Sources
    • 15.1.2 Secondary Data Sources
    • 15.1.3 Data Triangulation
  • 15.2 Market Estimation and Forecast
Product Code: BHP0827SC

List of Figures

  • Figure 1: Global Nucleic Acid Isolation and Purification Market (by Scenario), $Million, 2026, 2030, and 2036
  • Figure 2: Global Nucleic Acid Isolation and Purification Market (by Product), $Million, 2025, 2030, and 2036
  • Figure 3: Global Nucleic Acid Isolation and Purification Consumables Market (by Region), $Million, 2025, 2030, and 2036
  • Figure 4: Global Nucleic Acid Isolation and Purification Consumables Market (by Workflow), $Million, 2025, 2030, and 2036
  • Figure 5: Global Nucleic Acid Isolation and Purification Consumables Market (by Source Type), $Million, 2025, 2030, and 2036
  • Figure 6: Global Nucleic Acid Isolation and Purification Consumables Market (by Technology), $Million, 2025, 2030, and 2036
  • Figure 7: Global Nucleic Acid Isolation and Purification Consumables Market (by Downstream Application), $Million, 2025, 2030, and 2036
  • Figure 8: Global Nucleic Acid Isolation and Purification Consumables Market (by End User), $Million, 2025, 2030, and 2036
  • Figure 9: Global Nucleic Acid Isolation and Purification Instruments Market (by Region), $Million, 2025, 2030, and 2036
  • Figure 10: Global Nucleic Acid Isolation and Purification Instruments Market (by Workflow), $Million, 2025, 2030, and 2036
  • Figure 11: Global Nucleic Acid Isolation and Purification Instruments Market (by Technology), $Million, 2025, 2030, and 2036
  • Figure 12: Global Nucleic Acid Isolation and Purification Instruments Market (by Throughput), $Million, 2025, 2030, and 2036
  • Figure 13: Global Nucleic Acid Isolation and Purification Instruments Market (by End User), $Million, 2025, 2030, and 2036
  • Figure 14: Supply Chain of the Nucleic Acid Isolation and Purification Market
  • Figure 15: Global Cancer Incidence, 2018-2022
  • Figure 16: Global Nucleic Acid Isolation and Purification Market (by Product), $Million, 2025, 2030, and 2036
  • Figure 17: Global Nucleic Acid Isolation and Purification Market (Consumables), $Million, 2024-2036
  • Figure 18: Global Nucleic Acid Isolation and Purification Market (Kits), $Million, 2024-2036
  • Figure 19: Global Nucleic Acid Isolation and Purification Market (Reagents), $Million, 2024-2036
  • Figure 20: Global Nucleic Acid Isolation and Purification Market (Instruments), $Million, 2024-2036
  • Figure 21: Global Nucleic Acid Isolation and Purification Consumables Market (by Workflow), $Million, 2025, 2030, and 2036
  • Figure 22: Global Nucleic Acid Isolation and Purification Consumables Market (Sample Isolation/Extraction/Purification), $Million, 2024-2036
  • Figure 23: Global Nucleic Acid Isolation and Purification Consumables Market (DNA/RNA Clean-Up and Concentration), $Million, 2024-2036
  • Figure 24: Global Nucleic Acid Isolation and Purification Consumables Market (DNA/RNA Quantification), $Million, 2024-2036
  • Figure 25: Global Nucleic Acid Isolation and Purification Consumables Market (by Source Type), $Million,2025, 2030, and 2036
  • Figure 26: Global Nucleic Acid Isolation and Purification Consumables Market (DNA), $Million, 2024-2036
  • Figure 27: Global Nucleic Acid Isolation and Purification Consumables Market, DNA (Cell-Free DNA), $Million, 2024-2036
  • Figure 28: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Cell-Free DNA, By Sample Type, (Blood), $Million, 2024-2036
  • Figure 29: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Cell-Free DNA, By Sample Type, (Serum/Plasma), $Million, 2024-2036
  • Figure 30: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Cell-Free DNA, By Sample Type, (Other Sources), $Million, 2024-2036
  • Figure 31: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Cell-Free DNA, By Application, (Prenatal and Hereditary Testing), $Million, 2024-2036
  • Figure 32: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Cell-Free DNA, By Application, (Tumor Testing), $Million, 2024-2036
  • Figure 33: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Cell-Free DNA, By Application, (Transplantation), $Million, 2024-2036
  • Figure 34: Global Nucleic Acid Isolation and Purification Consumables Market, DNA (Genomic DNA), $Million, 2024-2036
  • Figure 35: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Genomic DNA (Blood), $Million, 2024-2036
  • Figure 36: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Genomic DNA (Body Fluids), $Million, 2024-2036
  • Figure 37: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Genomic DNA (Buccal), $Million, 2024-2036
  • Figure 38: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Genomic DNA (Cell/Cultured Cell), $Million, 2024-2036
  • Figure 39: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Genomic DNA (FFPE), $Million, 2024-2036
  • Figure 40: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Genomic DNA (Forensic), $Million, 2024-2036
  • Figure 41: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Genomic DNA (Plant), $Million, 2024-2036
  • Figure 42: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Genomic DNA (Saliva/Swab), $Million, 2024-2036
  • Figure 43: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Genomic DNA (Serum/Plasma), $Million, 2024-2036
  • Figure 44: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Genomic DNA (Tissue), $Million, 2024-2036
  • Figure 45: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Genomic DNA (Stool, Urine, and Other Samples), $Million, 2024-2036
  • Figure 46: Global Nucleic Acid Isolation and Purification Consumables Market, DNA (Microbial DNA), $Million, 2024-2036
  • Figure 47: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Microbial DNA (Bacterial), $Million, 2024-2036
  • Figure 48: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Microbial DNA (Fungus), $Million, 2024-2036
  • Figure 49: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Microbial DNA (Yeast), $Million, 2024-2036
  • Figure 50: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Microbial DNA (Other Sources), $Million, 2024-2036
  • Figure 51: Global Nucleic Acid Isolation and Purification Consumables Market, DNA (Plasmid DNA), $Million, 2024-2036
  • Figure 52: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Plasmid DNA (GigaPrep), $Million, 2024-2036
  • Figure 53: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Plasmid DNA (MaxiPrep), $Million, 2024-2036
  • Figure 54: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Plasmid DNA (MegaPrep), $Million, 2024-2036
  • Figure 55: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Plasmid DNA (MidiPrep), $Million, 2024-2036
  • Figure 56: Global Nucleic Acid Isolation and Purification Consumables Market, DNA, Plasmid DNA (MiniPrep), $Million, 2024-2036
  • Figure 57: Global Nucleic Acid Isolation and Purification Consumables Market, DNA (Viral DNA), $Million, 2024-2036
  • Figure 58: Global Nucleic Acid Isolation and Purification Consumables Market (RNA), $Million, 2024-2036
  • Figure 59: Global Nucleic Acid Isolation and Purification Consumables Market, RNA (Genomic RNA), $Million, 2024-2036
  • Figure 60: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Genomic RNA (Blood), $Million, 2024-2036
  • Figure 61: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Genomic RNA (Body Fluids), $Million, 2024-2036
  • Figure 62: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Genomic RNA (Cell/Cultured Cell), $Million, 2024-2036
  • Figure 63: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Genomic RNA (FFPE), $Million, 2024-2036
  • Figure 64: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Genomic RNA (Plant), $Million, 2024-2036
  • Figure 65: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Genomic RNA (Saliva/Swab), $Million, 2024-2036
  • Figure 66: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Genomic RNA (Serum/Plasma), $Million, 2024-2036
  • Figure 67: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Genomic RNA (Tissue), $Million, 2024-2036
  • Figure 68: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Genomic RNA (Urine), $Million, 2024-2036
  • Figure 69: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Genomic RNA (Others), $Million, 2024-2036
  • Figure 70: Global Nucleic Acid Isolation and Purification Consumables Market, RNA (Microbial RNA), $Million, 2024-2036
  • Figure 71: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Microbial RNA (Bacteria), $Million, 2024-2036
  • Figure 72: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Microbial RNA (Yeast), $Million, 2024-2036
  • Figure 73: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Microbial RNA (Fungus), $Million, 2024-2036
  • Figure 74: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Microbial RNA (Others), $Million, 2024-2036
  • Figure 75: Global Nucleic Acid Isolation and Purification Consumables Market, RNA (Viral RNA), $Million, 2024-2036
  • Figure 76: Global Nucleic Acid Isolation and Purification Consumables Market, RNA (Cell-Free RNA), $Million, 2024-2036
  • Figure 77: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Cell-Free RNA (Serum/Plasma), $Million, 2024-2036
  • Figure 78: Global Nucleic Acid Isolation and Purification Consumables Market, RNA, Cell-Free RNA (Others), $Million, 2024-2036
  • Figure 79: Global Nucleic Acid Isolation and Purification Consumables Market (by Technology), $Million, 2025, 2030, and 2036
  • Figure 80: Global Nucleic Acid Isolation and Purification Consumables Market (Silica-Based Technology), $Million, 2024-2036
  • Figure 81: Global Nucleic Acid Isolation and Purification Consumables Market (Magnetic Particle Technology), $Million, 2024-2036
  • Figure 82: Global Nucleic Acid Isolation and Purification Consumables Market (Other Technologies), $Million, 2024-2036
  • Figure 83: Global Nucleic Acid Isolation and Purification Consumables Market (by Downstream Applications), $Million, 2025, 2030, and 2036
  • Figure 84: Global Nucleic Acid Isolation and Purification Consumables Market (PCR), $Million, 2024-2036
  • Figure 85: Global Nucleic Acid Isolation and Purification Consumables Market (qPCR), $Million, 2024-2036
  • Figure 86: Global Nucleic Acid Isolation and Purification Consumables Market (NGS), $Million, 2024-2036
  • Figure 87: Global Nucleic Acid Isolation and Purification Consumables Market (Cloning), $Million, 2024-2036
  • Figure 88: Global Nucleic Acid Isolation and Purification Consumables Market (Microarray), $Million, 2024-2036
  • Figure 89: Global Nucleic Acid Isolation and Purification Consumables Market (Blotting Techniques), $Million, 2024-2036
  • Figure 90: Global Nucleic Acid Isolation and Purification Consumables Market (Other Applications), $Million, 2024-2036
  • Figure 91: Global Nucleic Acid Isolation and Purification Consumables Market (by End User), $Million, 2024-2036
  • Figure 92: Global Nucleic Acid Isolation and Purification Consumables Market (Academic Research Institutes and Laboratories), $Million, 2024-2036
  • Figure 93: Global Nucleic Acid Isolation and Purification Consumables Market (Pharmaceutical and Biotechnology Companies), $Million, 2024-2036
  • Figure 94: Global Nucleic Acid Isolation and Purification Consumables Market (Contract Research Organizations), $Million, 2024-2036
  • Figure 95: Global Nucleic Acid Isolation and Purification Consumables Market (Applied Testing), $Million, 2024-2036
  • Figure 96: Global Nucleic Acid Isolation and Purification Consumables Market (Clinical Diagnostic Centers), $Million, 2024-2036
  • Figure 97: North America Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 98: U.S. Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 99: Canada Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 100: Europe Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 101: Germany Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 102: U.K. Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 103: France Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 104: Italy Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 105: Spain Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 106: Netherlands Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 107: Poland Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 108: Portugal Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 109: Russia Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 110: Rest-of-Europe Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 111: Asia Pacific Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 112: Australia Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 113: China Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 114: India Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 115: Japan Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 116: Malaysia Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 117: South Korea Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 118: Thailand Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 119: Taiwan Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 120: Singapore Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 121: Indonesia Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 122: Philippines Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 123: Rest-of-Asia-Pacific Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 124: Latin America Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 125: Argentina Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 126: Brazil Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 127: Chile Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 128: Mexico Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 129: Colombia Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 130: Rest-of-Latin America Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 131: Middle East and Africa Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 132: K.S.A. Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 133: South Africa Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 134: U.A.E. Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 135: Rest-of-Middle East and Africa Nucleic Acid Isolation and Purification Consumables Market, $Million, 2024-2036
  • Figure 136: Global Nucleic Acid Isolation and Purification Instruments Market (by Workflow), $Million, 2025, 2030, and 2036
  • Figure 137: Global Nucleic Acid Isolation and Purification Instruments Market (Isolation/Extraction/Purification), $Million, 2024-2036
  • Figure 138: Global Nucleic Acid Isolation and Purification Instruments Market (Quality Control/Quantification), $Million, 2024-2036
  • Figure 139: Global Nucleic Acid Isolation and Purification Instruments Market, Quality Control/Quantification Instruments Market, by Technology (Spectrophotometers), $Million, 2024-2036
  • Figure 140: Global Nucleic Acid Isolation and Purification Instruments Market, Quality Control/Quantification Instruments Market, by Technology (Fluorometers), $Million, 2024-2036
  • Figure 141: Global Nucleic Acid Isolation and Purification Instruments Market, Quality Control/Quantification Instruments Market, by Technology (Others), $Million, 2024-2036
  • Figure 142: Global Nucleic Acid Isolation and Purification Instruments Market (by Technology), $Million, 2025, 2030, and 2036
  • Figure 143: Global Nucleic Acid Isolation and Purification Instruments Market (Automated Spin-Column based), $Million, 2024-2036
  • Figure 144: Global Nucleic Acid Isolation and Purification Instruments Market (Magnetic Bead Based), $Million, 2024-2036
  • Figure 145: Global Nucleic Acid Isolation and Purification Instruments Market (Automated Liquid Handling), $Million, 2024-2036
  • Figure 146: Global Nucleic Acid Isolation and Purification Instruments Market (by Throughput), $Million, 2025, 2030, and 2036
  • Figure 147: Global Nucleic Acid Isolation and Purification Instruments Market (Low-Throughput Instruments), $Million, 2024-2036
  • Figure 148: Global Nucleic Acid Isolation and Purification Instruments Market (Medium-Throughput Instruments), $Million, 2024-2036
  • Figure 149: Global Nucleic Acid Isolation and Purification Instruments Market (High-Throughput Instruments), $Million, 2024-2036
  • Figure 150: Global Nucleic Acid Isolation and Purification Instruments Market (by End User), $Million, 2025, 2030, and 2036
  • Figure 151: Global Nucleic Acid Isolation and Purification Instruments Market (Academic Research Institute), $Million, 2024-2036
  • Figure 152: Global Nucleic Acid Isolation and Purification Instruments Market (Pharmaceutical and Biotechnology Companies), $Million, 2024-2036
  • Figure 153: Global Nucleic Acid Isolation and Purification Instruments Market (Clinical Diagnostic Centers), $Million, 2024-2036
  • Figure 154: Global Nucleic Acid Isolation and Purification Instruments Market (Applied Testing (Biobanks, Forensic and Veterinary Laboratories)), $Million, 2024-2036
  • Figure 155: Global Nucleic Acid Isolation and Purification Instruments Market (Contract Research Organizations), $Million, 2024-2036
  • Figure 156: North America Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 157: U.S. Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 158: Canada Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 159: Europe Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 160: Germany Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 161: U.K. Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 162: France Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 163: Italy Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 164: Spain Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 165: Netherlands Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 166: Poland Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 167: Portugal Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 168: Russia Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 169: Rest-of-Europe Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 170: Asia Pacific Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 171: Australia Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 172: China Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 173: India Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 174: Japan Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 175: Malaysia Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 176: South Korea Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 177: Thailand Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 178: Taiwan Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 179: Singapore Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 180: Indonesia Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 181: Philippines Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 182: Rest-of-Asia-Pacific Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 183: Latin America Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 184: Argentina Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 185: Brazil Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 186: Chile Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 187: Mexico Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 188: Colombia Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 189: Rest-of-Latin America Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 190: Middle East and Africa Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 191: K.S.A. Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 192: South Africa Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 193: U.A.E. Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 194: Rest-of-Middle East and Africa Nucleic Acid Isolation and Purification Instruments Market, $Million, 2024-2036
  • Figure 195: Data Triangulation
  • Figure 196: Top-Down and Bottom-Up Approach
  • Figure 197: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Pricing of Market Available Consumables
  • Table 3: Pricing of Nucleic Acid Isolation and Purification Instruments by Product (Nucleic Acid Extraction Systems)
  • Table 4: Pricing of Nucleic Acid Isolation and Purification Instruments by Product (Liquid Handling and Automation Systems)
  • Table 5: Pricing of Nucleic Acid Isolation and Purification Instruments by Product (Sample Disruption & Homogenization Instruments)
  • Table 6: Selected Funding and Investment Activity
  • Table 7: Supply Chain Structure
  • Table 8: Global Nucleic Acid Isolation and Purification Market Regulatory Landscape
  • Table 9: Impact Analysis of Market Dynamics, 2024-2036
  • Table 10: Global Nucleic Acid Isolation and Purification Consumables Market (by Region), $Million, 2024-2036
  • Table 11: Low-Throughput Instruments
  • Table 12: Medium-Throughput Instruments
  • Table 13: High-Throughput Instruments
  • Table 14: Global Nucleic Acid Isolation and Purification Instruments Market (by Region), $Million, 2024-2036
  • Table 15: Nucleic Acid Isolation and Purification Consumables Market, Product Benchmarking (by Source Type, DNA)
  • Table 16: Nucleic Acid Isolation and Purification Consumables Market, Product Benchmarking (by Source Type, RNA)
  • Table 17: Nucleic Acid Isolation and Purification Instruments Market, Product Benchmarking (by Product Type)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!